Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICON6: Cediranib in Platinum-sensitive Relapsed Ovarian Cancer
NCT00532194Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Jul 2007
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cediranib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Medical Research Council. Status: unknown.
02
Drugs
cediranib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00532194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532194.